journal article·2025-02Open access

Boron Clusters Escort Doxorubicin Squashing Into Exosomes and Overcome Drug Resistance

Yi‐Ru Bao, Yi‐Jing Chen, Xue‐Fan Deng, Yi‐Ke Wang, Yu‐Xin Zhang, Li‐Li Xu, Wei‐Hua Huang, Shi‐Bo Cheng, Hai‐Bo Zhang, Min Xie

Advanced Science· Volume 12· Issue 7

Abstract

Abstract Exosome‐based drug delivery holds significant promise for cancer chemotherapy. However, current methods for loading drugs into exosomes are inefficient and cost‐prohibitive for practical application. In this study, boron clusters are mixed with doxorubicin (DOX) and exosomes, enabling the efficient encapsulation of DOX into exosomes through a superchaotropic effect. Exosomes loaded with DOX and boron clusters (EDB) exhibit superior permeability and the ability to deliver higher concentrations of DOX into DOX‐resistant breast cancer cells. Mechanistic analysis reveals that boron clusters form a supramolecular complex with DOX, which facilitates sustained drug release and effectively inhibits P‐glycoprotein‐mediated DOX efflux. As a result, EDB significantly enhance apoptosis in DOX‐resistant breast cancer cells and suppress tumor growth in cases where DOX alone is ineffective, thereby extending the survival of nude mice. In summary, boron clusters effectively facilitate the incorporation of DOX into exosomes and inhibit DOX efflux, offering a novel strategy to overcome DOX resistance.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · MicroRNA in disease regulation · MXene and MAX Phase Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Chemistry and Molecular Sciences Wuhan University 299 Bayi Road Wuhan 430072 P. R. China

College of Chemistry and Molecular Sciences Engineering Research Center of Organosilicon Compounds & Materials Ministry of Education and National Demonstration Center for Experimental Chemistry Wuhan University 299 Bayi Road Wuhan 430072 P. R. China

Department of Hepatobiliary and Pancreatic Surgery Zhongnan Hospital Wuhan University 169 East Lake Road Wuhan 430072 P. R. China

School of Laboratory Medicine Hubei University of Chinese Medicine 16 Huangjia Lake West Road Wuhan 430065 P. R. China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China

References (43)

Show source-provided references
1. 10.1158/0008-5472.CAN-07-661110.1158/0008-5472.CAN-07-6611 ↗
2. 10.1038/s41573-023-00723-410.1038/s41573-023-00723-4 ↗
3. 10.1016/j.lfs.2021.11952710.1016/j.lfs.2021.119527 ↗
4. 10.1016/j.jconrel.2020.08.03310.1016/j.jconrel.2020.08.033 ↗
5. 10.1016/j.ygyno.2005.10.02710.1016/j.ygyno.2005.10.027 ↗
6. 10.1200/JCO.2001.19.12.311710.1200/JCO.2001.19.12.3117 ↗
7. 10.1038/nrc359910.1038/nrc3599 ↗
8. 10.1177/10732748030100020710.1177/107327480301000207 ↗
9. 10.1021/acsami.7b0721910.1021/acsami.7b07219 ↗
10. 10.1038/nrc70610.1038/nrc706 ↗
11. 10.1038/s41568-018-0005-810.1038/s41568-018-0005-8 ↗
12. 10.1038/nrd198410.1038/nrd1984 ↗
13. 10.1126/science.aau697710.1126/science.aau6977 ↗
14. 10.3402/jev.v4.2706610.3402/jev.v4.27066 ↗
15. 10.1016/j.trac.2023.11731010.1016/j.trac.2023.117310 ↗
16. 10.1038/nri85510.1038/nri855 ↗
17. 10.1083/jcb.20121113810.1083/jcb.201211138 ↗
18. 10.1002/advs.20210527410.1002/advs.202105274 ↗
19. 10.1016/j.jconrel.2014.11.02910.1016/j.jconrel.2014.11.029 ↗
20. 10.1016/j.jconrel.2015.03.03310.1016/j.jconrel.2015.03.033 ↗
21. 10.1016/j.bioactmat.2022.02.01910.1016/j.bioactmat.2022.02.019 ↗
22. 10.1016/j.actbio.2019.10.02210.1016/j.actbio.2019.10.022 ↗
23. 10.1016/j.jconrel.2020.10.02010.1016/j.jconrel.2020.10.020 ↗
24. 10.1016/j.actbio.2020.06.03610.1016/j.actbio.2020.06.036 ↗
25. 10.1038/s41586-022-04413-w10.1038/s41586-022-04413-w ↗
26. 10.1002/anie.20180459710.1002/anie.201804597 ↗
27. 10.1021/jacs.3c0162310.1021/jacs.3c01623 ↗
28. 10.1002/anie.20220497910.1002/anie.202204979 ↗
29. 10.1002/ange.20141248510.1002/ange.201412485 ↗
30. 10.1002/smll.20210805510.1002/smll.202108055 ↗
31. 10.1039/C7CC06607D10.1039/C7CC06607D ↗
32. 10.1002/adfm.20200445210.1002/adfm.202004452 ↗
33. 10.1016/j.canlet.2015.10.02010.1016/j.canlet.2015.10.020 ↗
34. 10.1002/adhm.20210202710.1002/adhm.202102027 ↗
35. 10.1021/acsnano.3c0161210.1021/acsnano.3c01612 ↗
36. 10.1016/j.actbio.2023.06.00410.1016/j.actbio.2023.06.004 ↗
37. Dullinger P. · J. Am. Chem. Soc. · 2023 · 145
38. 10.1016/j.biopha.2018.09.03910.1016/j.biopha.2018.09.039 ↗
39. 10.1134/S181971242003004610.1134/S1819712420030046 ↗
40. 10.1016/j.apsb.2018.11.00510.1016/j.apsb.2018.11.005 ↗
41. 10.1007/s13402-014-0205-510.1007/s13402-014-0205-5 ↗
42. 10.1097/FPC.0b013e32833ffb5610.1097/FPC.0b013e32833ffb56 ↗
43. 10.1158/0008-5472.CAN-03-252410.1158/0008-5472.CAN-03-2524 ↗